EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 7 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 11.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,834 | +4.8% | 9,878 | 0.0% | 0.02% | -11.5% |
| Q2 2022 | $206,000 | -8.0% | 9,878 | 0.0% | 0.03% | 0.0% |
| Q1 2022 | $224,000 | +7.2% | 9,878 | 0.0% | 0.03% | +8.3% |
| Q3 2021 | $209,000 | -6.3% | 9,878 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $223,000 | -7.9% | 9,878 | 0.0% | 0.03% | -25.0% |
| Q3 2020 | $242,000 | +3.0% | 9,878 | 0.0% | 0.04% | -2.7% |
| Q2 2020 | $235,000 | +11.4% | 9,878 | 0.0% | 0.04% | +8.8% |
| Q2 2019 | $211,000 | -10.2% | 9,878 | 0.0% | 0.03% | -8.1% |
| Q1 2019 | $235,000 | +21.1% | 9,878 | 0.0% | 0.04% | +48.0% |
| Q4 2018 | $194,000 | +10.9% | 9,878 | 0.0% | 0.02% | -3.8% |
| Q3 2018 | $175,000 | -17.8% | 9,878 | 0.0% | 0.03% | -13.3% |
| Q2 2018 | $213,000 | – | 9,878 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |